References
- Kotani Y, Shimazawa M, Yoshimura S, Iwama T, Hara H. The experimental and clinical pharmacology of propofol, an anesthetic agent with neuroprotective properties. CNS Neurosci Ther 2008;14:95–106
- Wilson C, Canning P, Caravati EM. The abuse potential of propofol. Clin Toxicol (Phila) 2010;48:165–170
- Hartle A, Malhotra S. The safety of propofol. BMJ 2009;339:b4024
- Lee S, Lee MS, Kim YA, Ahn W, Lee HC. Propofol abuse of the medical personnel in operation room in Korea. Korean J Leg Med 2010;34:101–107
- Han E, Jung S, Baeck S, Lee S, Chung H. Deaths from recreational use of propofol in Korea. Forensic Sci Int 2013;233:333–337
- Kim D-K. Propofol use for sedation or sedation for propofol use? J Anesth 2012;26:289–291
- Kim R. Illegal drug use rises steeply. Available from: http://www.koreatimes.co.kr/www/news/nation/2011/09/117_95135.html 2011 [last accessed 14 Feb 2013]
- Virbac. Guidebook of Anesthetic Protocols – Cats. Available from: http://www.virbac.cz/zoletil_guide_cats.html [last accessed 14 Feb 2014]
- Redmond AH, Herman MI. Ingestion of Telazol®, a veterinary anaesthetic, by a 16 year-old male. Clin Intensive Care 2002;13:139–142
- Roussin A, Montastruc JL, Lapeyre-Mestre M. Pharmacological and clinical evidences on the potential for abuse and dependence of propofol: a review of the literature. Fundam Clin Pharmacol 2007;21:459–466
- Lee YK, Kang IG, Park CS, Heo SJ, Chai YS, Park SS, Lee JK, et al. A case of mental change in a patient who received a Zoletil injection. J Korean Soc Clin Toxicol 2013;11:23–27
- de la Pena JB, Lee HC, de la Pena IC, Woo TS, Yoon SY, Lee HL, Han JS, et al. Rewarding and reinforcing effects of the NMDA receptor antagonist-benzodiazepine combination, Zoletil®: difference between acute and repeated exposure. Behav Brain Res 2012;233:434–442
- de la Pena JB, Yoon SY, de la Pena IC, Lee HL, de la IPIJ, Cheong JH. Pre-exposure to related substances induced place preference and self-administration of the NMDA receptor antagonist-benzodiazepine combination, Zoletil®. Behav Pharmacol 2012;24:20–28
- de la Peña JBI, Lee HL, Shin CY, Sohn AR, Cheong JH. Pre-exposure to ethanol, but not to caffeine and nicotine, induced place preference and self-administration of the NMDA receptor antagonist-benzodiazepine combination, Zoletil®. Pharmacol Biochem Behav 2013;110:231–237
- Gardner EL. What we have learned about addiction from animal models of drug self-administration. Am J Addict 2000;9:285–313
- Bardo MT, Bevins RA. Conditioned place preference: what does it add to our preclinical understanding of drug reward? Psychopharmacology (Berl) 2000;153:31–43
- Pain L, Oberling P, Sandner G, Di Scala G. Effect of propofol on affective state as assessed by place conditioning paradigm in rats. Anesthesiology 1996;85:121–128
- European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Polydrug use. Annual report of the EMCDDA 2002
- Boys A, Marsden J, Griffiths P, Fountain J, Stillwell G, Strang J. Substance use among young people: the relationship between perceived functions and intentions. Addiction 1999;94:1043–1050
- European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Polydrug use: patterns and responses. Annual Report of the EMCDDA 2009
- Cha HJ, Cha J-H, Cho H-Y, Chung E-Y, Kwon K-J, Lee JY, Jeong H-S, et al. Dependence potential of propofol: behavioral pharmacology in rodents. Biomol Ther (Seoul) 2012;20:234–238
- Krasowski MD, Koltchine VV, Rick CE, Ye Q, Finn SE, Harrison NL. Propofol and other intravenous anesthetics have sites of action on the γ-aminobutyric acid type A receptor distinct from that for isoflurane. Mol Pharmacol 1998;53:530–538
- Krasowski MD, Jenkins A, Flood P, Kung AY, Hopfinger AJ, Harrison NL. General anesthetic potencies of a series of propofol analogs correlate with potency for potentiation of γ-aminobutyric acid (GABA) current at the GABAA receptor but not with lipid solubility. J Pharmacol Exp Ther 2001;297:338–351
- Orser BA, Bertlik M, Wang LY, MacDonald JF. Inhibition by propofol (2, 6 di-isopropylphenol) of the N-methyl-D-aspartate subtype of glutamate receptor in cultured hippocampal neurones. Br J Pharmacol 1995;116:1761–1768
- Roberge C, Beaudet M-J, Anderson A. GABAA central benzodiazepine receptor and peripheral benzodiazepine receptor ligands as inducers of phenobarbital-inducible CYP2B and CYP3A. Biochem Pharmacol 2004;68:1383–1389
- UNODC. World Drug Report 2013. United Nations publication 2013; Sales No. E.13.XI.6
- EMCDDA–Europol. New drugs in Europe, 2012. Annual Report of the European Monitoring Centre for Drugs and Drug Addiction and European Police Office 2013